Does the Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Differ According to the Type of EGFR Mutation in Non-Small Cell Lung Cancer?

Korean Journal of Internal Medicine - South Korea
doi 10.3904/kjim.2016.190
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Association of Internal Medicine


Related search